News - 06 Feb `23Vitiligo Clinical Trials update

New

Clinical trials are experiments that test how well new drugs, treatments or devices work in people. Trials progress through Phases I-IV to test a drug candidate, find the appropriate dosage, and look for side effects. The goal is to determine whether a medicine is both safe and effective. Drug candidates that have entered into clinical trials or pending approval by the U.S. Food and Drug Administration (FDA) are often said to be "in the pipeline." 

Our Trials Hub provides a comprehensive list of more than 20 active clinical trials located in Bangladesh, Canada, Egypt, France, Israel, and the United States.

👉 UPDATE February 6, 2023: New study posted "A Phase 1, Single and Multiple Ascending Dose (SAD/MAD) Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of VYN201 in Healthy Volunteers and in Subjects with Non-Segmental Vitiligo (NSV)" from Vyne Therapeutics.

Our CEO Yan Valle analyzes and monitors the entire drug development landscape along with the trends shaping and driving the vitiligo market, and reports findings in Vitiligo Drug Pipeline Analysis and Market Insights

 

Vitiligo clinical trials selector

 



      FAQOther Questions

      • Are there any famous people with vitiligo?

        Many celebrities have dealt with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career. Here are a few courageous famous peo...

      • Is vitiligo contagious?

        Vitiligo is not contagious. This means it cannot be spread from person to person through physical contact, sharing personal items, or any other means of transmission. Vitiligo ...

      • Who is prone to vitiligo?

        Vitiligo can affect anyone, regardless of gender, age, or race. Vitiligo prevalence is between 0.76% and 1.11% of the U.S. population, including around 40% of those with the con...